Segall Bryant & Hamill’s Axogen AXGN Stock Holding History

Segall Bryant & Hamill’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-59,028	Closed	-$1.05M	–	785
2019 Q4	$1.05M	Sell	59,028 -26,729	-31%	-$395K	0.02%	509
2019 Q3	$1.07M	Sell	85,757 -2,266	-3%	-$37.3K	0.02%	506
2019 Q2	$1.74M	Buy	88,023 +2,025	+2%	+$43.3K	0.03%	433
2019 Q1	$1.81M	Sell	85,998 -630	-0.7%	-$11.5K	0.03%	425
2018 Q4	$1.77M	Buy	86,628 +30,039	+53%	+$940K	0.03%	422
2018 Q3	$2.08M	Buy	+56,589	New	+$2.47M	0.03%	427

Other funds holding AXGN

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Segall Bryant & Hamill's AXGN Position: Q1 2020 in Review

Segall Bryant & Hamill sold out of Axogen (AXGN) in Q1 2020, closing a stake of 59,028 shares — an estimated $1.05M sold.

Segall Bryant & Hamill first reported a position in AXGN in Q3 2018 and held it in 6 quarters. The position peaked at $2.08M in Q3 2018. 116 funds tracked by Wall St. Rank hold AXGN as of Q1 2020.

Segall Bryant & Hamill reported no remaining Axogen position as of Q1 2020 after selling out during the quarter.
Segall Bryant & Hamill sold 59,028 Axogen shares in Q1 2020, an estimated $1.05M.
Segall Bryant & Hamill first reported a position in Axogen in Q3 2018 and held it in 6 quarters.
Segall Bryant & Hamill's Axogen position peaked at $2.08M in Q3 2018.
116 funds tracked by Wall St. Rank held Axogen as of Q1 2020.

Based on Segall Bryant & Hamill's 13F filing for Q1 2020, filed 14 May 2020.